Published in J Clin Invest on May 01, 1962
Liver in Felty's syndrome. Br Med J (1970) 2.75
A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging (2012) 2.18
The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest (1976) 1.59
Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes (2008) 1.35
Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest (1996) 1.33
Preoperative assessment of portal hypertension. Ann Surg (1967) 1.28
Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest (1991) 1.22
Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest (1977) 1.19
Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. J Clin Invest (1974) 1.18
Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest (1974) 1.17
Sources of carbon for hepatic glycogen synthesis in the conscious dog. J Clin Invest (1991) 1.15
Role of insulin in the regulation of leucine kinetics in the conscious dog. J Clin Invest (1982) 1.15
Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. J Clin Invest (1987) 1.13
Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest (1994) 1.09
Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man. J Clin Invest (1982) 1.03
Whole body and splanchnic blood flow and oxygen consumption measurements in patients with intraperitoneal infection. Ann Surg (1970) 1.01
Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest (1991) 0.95
Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users. CNS Neurol Disord Drug Targets (2011) 0.95
Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest (1997) 0.93
A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin. Am J Physiol Endocrinol Metab (2009) 0.93
LIVER FUNCTION IN ADVANCED HEART DISEASE. Br Heart J (1965) 0.93
Cocaine hydrolase gene therapy for cocaine abuse. Future Med Chem (2012) 0.90
Mechanisms of epinephrine-induced glucose intolerance in normal humans. J Clin Invest (1982) 0.89
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green. Br J Clin Pharmacol (1991) 0.86
Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs. J Pharmacol Exp Ther (2011) 0.86
The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition. Br J Clin Pharmacol (1985) 0.84
Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy. World J Gastroenterol (2005) 0.83
Hepatic blood flow measurement. A comparison of the indocyanine green and electromagnetic techniques normal and abnormal flow states in the dog. Ann Surg (1977) 0.82
Hepatic drug clearance: the effect of age using indocyanine green as a model compound. Br J Clin Pharmacol (1990) 0.82
Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis? Dig Dis Sci (2002) 0.82
Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest (1989) 0.82
A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo. Diabetes (2010) 0.82
Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects. Br J Clin Pharmacol (1990) 0.81
Could quantitative liver function tests gain wide acceptance among hepatologists? World J Gastroenterol (2009) 0.80
BLOOD TRIGGERED RAPID RELEASE POROUS NANOCAPSULES. RSC Adv (2013) 0.80
Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. J Clin Invest (1984) 0.79
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs. Eur J Pharmacol (2009) 0.79
Hepatic blood flow: accuracy of estimation from infusions of indocyanine green in anaesthetized cats. Br J Pharmacol (1987) 0.79
Vascular assessment of liver disease-towards a new frontier in MRI. Br J Radiol (2016) 0.78
Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green. Eur J Appl Physiol (2010) 0.78
Inbuilt mechanisms for overcoming functional problems inherent in hepatic microlobular structure. Comput Math Methods Med (2011) 0.77
Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles. Nat Commun (2014) 0.77
The role of salivary caffeine clearance in the diagnosis of chronic liver disease. J Oral Biol Craniofac Res (2015) 0.76
Effect of lignocaine on arginine-vasopressin plasma levels: baseline or induced by frusemide. Br J Pharmacol (1992) 0.76
Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy. Eur J Med Res (2009) 0.76
Effects of an angiotensin II antagonist on organ perfusion during the post-resuscitation phase in pigs. Crit Care (1998) 0.75
Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis. Br J Clin Pharmacol (1994) 0.75
Portal hypertension--current status. Calif Med (1969) 0.75
Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery? World J Hepatol (2016) 0.75
Combined hepatic vein, umbilicoportal vein, and superior mesenteric artery catheterization in portal hypertension: estimation of the portal fraction of total hepatic blood flow in cirrhotic patients. Yale J Biol Med (1975) 0.75
Monocytes loaded with indocyanine green as active homing contrast agents permit optical differentiation of infectious and non-infectious inflammation. PLoS One (2013) 0.75
OBSERVATIONS ON INTRAHEPATIC VASCULAR PRESSURE REGULATION IN PORTAL HYPERTENSION. Ann Surg (1963) 0.75
THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN. J Clin Invest (1945) 20.72
The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci (1961) 6.71
Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med (1956) 5.91
THE HEPATIC BLOOD FLOW AND SPLANCHNIC OXYGEN CONSUMPTION OF MAN-THEIR ESTIMATION FROM UREA PRODUCTION OR BROMSULPHALEIN EXCRETION DURING CATHETERIZATION OF THE HEPATIC VEINS. J Clin Invest (1947) 4.79
Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest (1960) 4.66
Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow. J Lab Clin Med (1950) 2.26
The distribution and excretion of S35-labeled sulfobromophthalein-sodium administered to dogs by continuous infusion. J Clin Invest (1955) 2.19
The disappearance rate of colloidal radio-gold from the circulation and its application to the estimation, of liver blood flow in normal and cirrhotic subjects. J Clin Invest (1954) 1.91
Evaluation of a new cuvette densitometer for determination of cardiac output. Circ Res (1953) 1.84
The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis (1960) 1.64
Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med (1958) 1.55
The estimation of hepatic blood flow and intrahepatic shunted blood flow by colloidal heat-denatured human serum albumin labeled with I-131. J Clin Invest (1961) 1.47
The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents. J Clin Invest (1961) 1.28
The estimation of hepatic blood flow using indocyanine green. Surg Gynecol Obstet (1960) 1.26
Enterohepatic circulation of bromsulphalein: intraduodenal, intraportal and intravenous dye administration in dogs. Am J Physiol (1953) 1.24
Estimation of hepatic blood flow in man and in dogs by I 131-labeled rose bengal; simultaneous comparison with sulfobromophthalein sodium. J Lab Clin Med (1960) 1.07
Measurement of hepatic blood flow in the unanesthetized dog by a modified bromsulphalein method. J Appl Physiol (1960) 1.06
Determination of hepatic blood flow in man by cardio green. Scand J Clin Lab Invest (1960) 1.05
Determination of the hepatic blood flow by galactose. Dan Med Bull (1954) 1.00
MEASUREMENT OF BLOOD FLOW IN THE COLLATERAL VESSELS OF THE PORTAL VEIN; PRELIMINARY RESULTS OF A NEW METHOD. J Clin Invest (1960) 1.00
[Kinetics of phagocytosis of especially prepared and radiolabelled human serum albumin and its use in the study of liver circulation in humans]. C R Seances Soc Biol Fil (1956) 0.96
Observations on norethandrolone-induced abnormalities in plasma decay of sulfobromophthalein and indocvanine green. J Lab Clin Med (1961) 0.94
False-negative bromsulfalein tests. N Engl J Med (1961) 0.93
A single scale absolute reading ear oximeter. Proc Staff Meet Mayo Clin (1950) 0.90
Inefficient hepatic extraction of colloidal gold: resulting inaccuracies in determination of hepatic blood flow. J Lab Clin Med (1959) 0.89
Practical and research value of hepatic-vein catheterization. N Engl J Med (1958) 0.83
Measurement of hepatic blood flow by clearance methods; a review and a theoretical basis for a new noncatheterization method. Am J Dig Dis (1958) 0.82
A sensitive and stable earpiece for dye dilution curves. Br Heart J (1960) 0.82
Estimation of total circulating sodium. J Am Med Assoc (1955) 0.81
Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest (1960) 4.66
Metabolic deficiencies in protozoa induced by thalidomide. Science (1963) 1.57
Hyperglycemia and glycosuria in the chronic alcoholic with hepatic insufficiency; clinical observations in 10 patients. Am J Med Sci (1952) 1.42
Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine (Baltimore) (1962) 1.33
Clinical estimation of liver size. Am J Dig Dis (1963) 1.32
PERIPHERAL NEUROPATHY OF THE ALCOHOLIC: I, AETIOLOGICAL ROLE OF ANEURIN AND OTHER B-COMPLEX VITAMINS. Br Med J (1964) 1.31
B-COMPLEX VITAMINS IN LIVER DISEASE OF THE ALCOHOLIC. Am J Clin Nutr (1965) 1.29
THE FATE OF ORALLY AND PARENTERALLY ADMINISTERED FOLATES. Am J Clin Nutr (1965) 1.27
Practical and research value of hepatic-vein catheterization. N Engl J Med (1958) 1.23
The liver in congestive heart failure. Am Heart J (1955) 1.11
Effect of ethanol on plasma free fatty acids in man. J Lab Clin Med (1962) 1.11
SERUM ALBUMIN TURNOVER IN NORMAL SUBJECTS AND PATIENTS WITH CIRRHOSIS MEASURED BY 131I-LABELLED HUMAN ALBUMIN. Clin Sci (1963) 1.09
Liver regeneration in experimental carbon tetrachloride intoxication. Proc Soc Exp Biol Med (1960) 1.08
Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease. N Engl J Med (1960) 1.03
Clinical observations on the fatty liver. AMA Arch Intern Med (1953) 1.00
PHYSIOLOGY OF DYE EXTRACTION BY THE LIVER: COMPARATIVE STUDIES OF SULFOBROMOPHTHALEIN AND INDOCYANINE GREEN. Ann N Y Acad Sci (1963) 1.00
Observations on hepatic oxygen metabolism in man. JAMA (1961) 0.98
Diabetes mellitus and liver dysfunction; etiologic and therapeutic considerations. Am J Med (1950) 0.98
Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis. Ann Intern Med (1958) 0.97
Observations on the distribution of C14 oxytetracycline in man. Antibiot Annu (1959) 0.96
Observations on norethandrolone-induced abnormalities in plasma decay of sulfobromophthalein and indocvanine green. J Lab Clin Med (1961) 0.94
Observations on the effect of portacaval anastomosis upon the hemodynamics of the liver. Surg Gynecol Obstet (1959) 0.94
False-negative bromsulfalein tests. N Engl J Med (1961) 0.93
TRANSKETOLASE ACTIVITY IN EXPERIMENTAL THIAMINE DEFICIENCY AND HEPATIC NECROSIS. Proc Soc Exp Biol Med (1965) 0.90
THE EFFECT OF ETHANOL UPON SYSTEMIC AND HEPATIC BLOOD FLOW IN MAN. Am J Clin Nutr (1963) 0.89
Radioisotope scanning as a guide to needle biopsy of the liver. Am J Med Sci (1957) 0.88
MESENCHYMAL-CELL PROLIFERATION IN LIVER DISEASE OF THE ALCOHOLIC. JAMA (1964) 0.87
Hepatic abnormalities in congestive heart failure; needle biopsy studies. Circulation (1951) 0.87
CLINICAL ASPECTS OF THE HEPATIC CIRCULATION. Gastroenterology (1965) 0.86
Hemodynamic effects of posterior pituitrin in cirrhosis. Surg Forum (1960) 0.85
The liver in extrahepatic biliary obstruction. Am J Med Sci (1954) 0.84
Clinical observations on hepatic fibrosis. AMA Arch Intern Med (1955) 0.84
EFFECT OF HEPATIC DISEASE ON LIVER B-COMPLEX VITAMIN TITERS. Am J Clin Nutr (1964) 0.84
Cholecystography in portal cirrhosis without jaundice. Gastroenterology (1953) 0.83
Portal hypertension. N Engl J Med (1960) 0.83
Practical and research value of hepatic-vein catheterization. N Engl J Med (1958) 0.83
A METHOD FOR ASSAYING THIAMINE STATUS IN MAN AND ANIMALS. Am J Clin Nutr (1964) 0.82
Estimation of total circulating sodium. J Am Med Assoc (1955) 0.81
[Not Available]. Diabetes (1959) 0.80
Dye extraction by the liver. Prog Liver Dis (1961) 0.79
PRIMARY LIVER CANCER IN CIRRHOSIS OF THE ALCOHOLIC. Ann N Y Acad Sci (1964) 0.79
Hepatic abnormalities in alcoholics with delirium tremens. Q J Stud Alcohol (1953) 0.79
Liver regeneration. Arch Intern Med (1960) 0.78
Diuresis in congestive heart failure. J Med Soc N J (1951) 0.77
Body sodium disturbances. J Natl Med Assoc (1954) 0.75
Medical pioneers. J Natl Med Assoc (1962) 0.75
The diagnostic and therapeutic value of liver biopsy. J Natl Med Assoc (1957) 0.75
OBSERVATIONS ON INTRAHEPATIC VASCULAR PRESSURE REGULATION IN PORTAL HYPERTENSION. Ann Surg (1963) 0.75
Intrahepatic cholestasis. Am J Surg (1959) 0.75
PORTAL HYPERTENSION AND BLEEDING. Mod Treat (1964) 0.75
Observations on the mode of action and clinical effects of chlorpropamide in diabetes mellitus. Ann N Y Acad Sci (1959) 0.75
FOLIC ACID DEFICIENCY AND HEPATIC DNA SYNTHESIS. Proc Soc Exp Biol Med (1964) 0.75
Problems in the differential diagnosis of jaundice. Rev Gastroenterol (1953) 0.75
Needle biopsy of the liver; a critical evaluation. J Med Soc N J (1949) 0.75
An alkali resistant factor with B12 activity for protozoa and man. Experientia (1962) 0.75
Observations on effects of anesthesia on B complex vitamin levels in tissue. Surg Forum (1961) 0.75
ALTERATIONS IN CIRCULATING FOLATE INDUCED BY B12 DEFICIENCY. Proc Soc Exp Biol Med (1964) 0.75
VITAMIN-BINDING CAPACITY OF EXPERIMENTALLY INJURED LIVER. Nature (1964) 0.75
Fluids in congestive heart failure. J Am Med Assoc (1946) 0.75
CONVERSION OF DIOPTERIN AND TEROPTERIN INTO FOLIC AND FOLINIC ACID ACTIVITY BY THE RAT LIVER. Proc Soc Exp Biol Med (1964) 0.75
The liver in diabetes mellitus. J Med Soc N J (1958) 0.75
METABOLIC AND NUTRITIONAL EFFECTS OF ALCOHOLISM. Arch Environ Health (1963) 0.75
Organization and function of a clinic for the alcoholic patient with liver disease. I. Effect of rehabilitation on hepatic abnormalities. Q J Stud Alcohol (1954) 0.75
The effects of sodium dextro-thyroxin on lipid metabolism in primary biliary cirrhosis. Gastroenterology (1962) 0.75
Protein tolerance in liver disease. Am J Clin Nutr (1962) 0.75
Alterations in serum triglyceride levels in liver disease. Gastroenterology (1962) 0.75
Absorption of orally administered neomycin and kanamycin, with special reference to patients with severe hepatic and renal diseases. Antibiot Annu (1960) 0.75
HEPATIC DNA SYNTHESIS AND REGENERATION. Biochem Clin (1964) 0.75
EFFECT OF HEPATIC NECROSIS AND REGENERATION ON FOLIC ACID CONJUGASE AND REDUCTASE ACTIVITY. Exp Mol Pathol (1964) 0.75
[Clinical and laboratory tests of liver diseases]. Resen Clin Cient (1957) 0.75
Diagnostic value of radiologic studies in liver disease. J Med Soc N J (1959) 0.75
MANAGEMENT OF ASCITES. Arch Intern Med (1963) 0.75
Carbohydrate disturbances in liver disease. J Med Soc N J (1953) 0.75
[Functional studies of the liver]. Nicar Med (1962) 0.75
Nutritional factors in liver disease in man: a review. Am J Clin Nutr (1959) 0.75
Functional evaluation of the liver. N Y State J Med (1958) 0.75
Treatment of menincococcic meningitis. J Med Soc N J (1947) 0.75
Portal hypertension. N Engl J Med (1960) 0.75
Neohydrin; a new oral mercurial diuretic. Int Rec Med Gen Pract Clin (1953) 0.75